ABOUT CLINICAL INK
Clinical ink is the global life science company that brings data, technology, and patient science together.
Our deep therapeutic-area expertise, coupled with Direct Data Capture, eCOA, eConsent, telehealth, neurocognitive testing, and digital biomarkers advancements, drive the industry standard for data precision and usher in a new generation of clinical trials.
By harnessing digital data, we power sponsors, CROs, researchers, and patients to recenter decentralized trials and rewrite the clinical development experience.
For more information, visit www.clinicalink.com
FEATURED ARTICLES
-
![Telehealth virtual ipad elderly]( "eSource Enables Speed, Flexibility, And Higher-Quality Data")
A truly integrated eSource Solution, including DDC, eCOA, and eConsent, facilitates remote or decentralized clinical trials by ingesting data from multiple sources and consolidating it into a single data set.
-
![GettyImages-1390654899 esource patient]( "Straight From The Source: How Capturing Data Directly Is Transforming Trials")
With the right eSource technology, trial data can be aggregated, integrated, and classified to accelerate data analysis for insight-based decisions in real time.
-
![GettyImages-873473740 esource patient]( "eSource: Power To The Patient")
eSource technologies allow Sponsors to center trials on patients and their needs as never before. This advancement of clinical trials can thus be based on comprehensive, actionable, patient-centered measures and assessments.
-
![GettyImages-1170544407 doctor value]( "The False Economy Of Paper Diaries In Clinical Trials")
While paper diaries may appear cheaper, but there are hidden costs that make a digital eCOA solution much more affordable in your clinical trial.
-
![Optimizing Rare Disease Outcomes Through eCOA Technology And Training]( "One eCOA Solution For All Protocol Requirements")
Improve trial efficiency, quality, and safety by accessing Clinical inkl's large assortment of clinical outcomes assessments for a wide range of phases and therapeutic areas.
-
![GettyImages-1447084050 data]( "Gradually Investing In Direct Data Capture Is Inevitable")
Given the decentralization of clinical trials and the many electronic sources of data now available, it is time for sponsors and contract research organizations to face the inevitable: EDCs need to be “sunsetted.”
-
![Doctor-Patient-Question-Network]( "DDC vs. EDC: Frequently Asked Questions")
Direct Data Capture (DDC) and Electronic Data Capture (EDC). They sound the same. But when you dig a little deeper, there are fundamental, crucial distinctions that make a significant difference in clinical research workflows, data quality, and timelines.
-
![gettyimages-1357522266-170667a]( "DDC Is The Smarter Option For Your Clinical Studies")
Learn the fundamental, crucial distinctions between Direct Data Capture and Electronic Data Capture that make a significant impact on clinical research workflows, data quality, and timelines.
-
![digital tablet GettyImages-1373659740]( "Better Experience And Faster Startup With Clinical ink eConsent")
Clinical ink’s eConsent technology optimizes your Informed Consent (ICF) process. By combining electronic form workflows and interactive question and answer sections, it offers a dynamic, easily understandable patient and user experience.
-
![Wearable iStock-1257436276]( "Harness The Power Of Sensors And Wearables")
Enable patient science via mobile assessments engineered by advanced clinical, software, data, and user experience experts. Power patient outcomes with Clinical ink.
-
![GettyImages-1327073750 ps]( "Digital Biomarkers As Endpoints In Parkinson’s Disease")
Gain an in-depth understanding of how digital biomarkers are being developed for Parkinson's Disease, and an outlook on how advances in technology will drive a shift toward remote data collection in clinical trials.
CONTACT INFORMATION
Clinical ink
110 Gibraltar Road, Suite 150
Horsham, PA 19044
UNITED STATES
Phone: 336-714-7402 ext. 722
Contact: Nina Pruitt
CASE STUDIES
-
![iStock-1280184645-patient-masks-pandemic-doctor]( "Real-Time, Remote Data Collection For Faster Trial Deployment")
A leading pharma company was planning a Phase III trial for a SARS-CoV-2 prophylactic therapy and needed to evaluate post-exposure prophylaxis and preemptive treatment in 1,000+ patients at 82 sites. Explore how eSource was rapidly deployed for clinical trial success.
-
![cell phone data iStock-1274394138]( "A Purpose-Built eCOA: Reduce Site And Patient Burden In Gastroenterology Trials")
Learn how a purpose-built solution designed to overcome the significant, but typical, challenges of a complex GI trial enables improved trial conduct and a better deployment experience.
-
![Clinical Data]( "92% Accuracy In Early Parkinson’s Classification")
Academic researchers and two biopharma leaders teamed up with Clinical ink in the WATCH-PD Study to test the power of at-home mobile devices to assess Parkinson’s Disease progression. The work, described here, is an important step in seeking regulators’ qualification of novel digital assessments in early Parkinson’s Disease.
-
![scientist laboratory research iStock-942266140]( "How Translation Teamwork Generates Cost Savings For Global Trials")
eCOA translations don’t have to be overly complicated or time-consuming. When vendors work together, they create efficiencies that benefit both the sponsor and the patients. This article explains how translation specialist RWS and Clinical Ink collaborated to create a new tool that streamlines review and approval of translated eCOA screens.
-
![teen patient with ipad iStock-1031551128]( "Teens Give Thumbs Up To Electronic Diabetes Assessments")
In order to ensure a fluid experience for a patient, usability testing is a critical data point to consider. Addressing both a patient’s needs and access to a digital platform is key to data collection. TransPerfect, along with our partners from Parexel, Clinical Ink, and Health Psychology Research, recently published a poster at the Virtual ISPOR Europe 2020 conference that reviews the impact of moving from in-person to electronic data collection.
MEDIA
-
![clinical ink biomarker video]( "Robust, Scalable Analytics To Develop Digital Biomarkers")
Clinical ink offers a best-in-class analytics platform to support the development and evaluation of digital biomarkers in clinical trials.
-
![clinical ink ecoa]( "Smarter eCOA With Clinical ink")
Deploy a smarter, faster, simpler eCOA with Clinical ink, powered by deep outcomes science expertise across many therapeutic areas.
-
![1_0046DED9D4CB3F42A59BB60BB568FA77]( "Reducing Complexity In Lupus Clinical Studies")
Lupus is a complicated disease, characterized by an aggregation of symptoms, which can vary from patient to patient and makes diagnosis difficult. For clinical research, this variability in the manifestation of the disease also increases complexity of data collection. Documentation requirements for a lupus research study are extensive – far more than a typical patient medical chart. And data variability can obscure the ability to detect improvement in disease activity.
-
![GettyImages-1313904463 ps]( "Mobile Assessments For Parkinson’s Disease Research")
In this video, see firsthand fit-for-purpose mobile assessments and applications designed to measure endpoints in Parkinson’s Disease.
-
![1_E6547E32C0893EBF5EC770EBD7015974]( "The Digital Frontier of Parkinson's Research: Advancing a New Age of Clinical Discovery")
Parkinson's research is evolving, with a dramatic increase in patient involvement, advanced systems of measurement, and real-world data gathering at the forefront. Subjective assessments and endpoints can now be augmented with richer data sources gathered directly via wearables, sensors, and mobile technology. Beyond enabling data collection outside the clinic, these models, tied to existing gold standard measurements, enhance all stakeholders' abilities to access more sensitive, frequent, and objective measures of Parkinson’s progression.
